(0.13%) 5 220.92 points
(0.29%) 39 503 points
(-0.07%) 16 334 points
(-1.12%) $78.37
(-1.78%) $2.26
(1.39%) $2 372.90
(0.32%) $28.46
(1.67%) $1 007.30
(0.11%) $0.928
(-0.20%) $10.84
(-0.03%) $0.798
(0.11%) $92.65
3 days till quarter result
(bmo 2024-05-13)
Expected move: +/- 7.78%
Live Chart Being Loaded With Signals
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma...
Stats | |
---|---|
Today's Volume | 241 890 |
Average Volume | 222 227 |
Market Cap | 47.30M |
EPS | $-0.250 ( 2024-03-26 ) |
Next earnings date | ( $-0.270 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.750 |
ATR14 | $0.0100 (1.06%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-08 | Matheis Dennis | Buy | 241 500 | Employee stock option (right to buy) |
2024-05-06 | Matheis Dennis | Sell | 0 | Common stock |
2024-05-07 | Gordon Michael Adam | Buy | 400 000 | Common stock |
2024-05-07 | O'neil Shaun | Buy | 400 000 | Common stock |
2024-05-07 | Mcgrath Dennis M | Buy | 400 000 | Common stock |
INSIDER POWER |
---|
44.28 |
Last 63 transactions |
Buy: 15 024 819 | Sell: 4 158 892 |
Volume Correlation
Lucid Diagnostics Inc. Correlation
10 Most Positive Correlations | |
---|---|
HCDIP | 0.958 |
NLSP | 0.954 |
HAIN | 0.951 |
SIRI | 0.945 |
NOVN | 0.943 |
TRVN | 0.942 |
PHCF | 0.941 |
RMGC | 0.937 |
TTEC | 0.937 |
FRHC | 0.936 |
10 Most Negative Correlations | |
---|---|
TRMR | -0.96 |
VITL | -0.951 |
THRN | -0.941 |
ARTEU | -0.94 |
GGAL | -0.939 |
DXPE | -0.937 |
RZLT | -0.935 |
CDXC | -0.935 |
GHRS | -0.934 |
IXAQ | -0.932 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Lucid Diagnostics Inc. Correlation - Currency/Commodity
Lucid Diagnostics Inc. Financials
Annual | 2023 |
Revenue: | $2.43M |
Gross Profit: | $-6.05M (-249.18 %) |
EPS: | $-1.260 |
FY | 2023 |
Revenue: | $2.43M |
Gross Profit: | $-6.05M (-249.18 %) |
EPS: | $-1.260 |
FY | 2022 |
Revenue: | $377 000 |
Gross Profit: | $-3.24M (-858.62 %) |
EPS: | $-1.550 |
FY | 2021 |
Revenue: | $500 000 |
Gross Profit: | $-85 000.00 (-17.00 %) |
EPS: | $-1.510 |
Financial Reports:
No articles found.
Lucid Diagnostics Inc.
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its lead products include EsoGuard, a laboratory developed esophageal DNA test; and EsoCheck, an esophageal cell collection device. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators